FDA chief: Changing generics regulations could reel in drug prices

Part of the FDA commissioner’s job is to oversee the federal regulatory watchdog as it evaluates pharmaceuticals for safety and efficacy. Most FDA chiefs have avoided the topic of drug prices, given that it isn’t a clearly-stated part of the agency’s mission
But just 2 weeks into the job, newly-confirmed FDA commish Dr. Scott Gottlieb proposed a plan, called the Drug Competition Action Plan, that he believes will help restrain the cost of prescription drugs.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA chief: Changing generics regulations could reel in drug prices appeared first on MassDevice.

Source: Mass Device - May 25, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Healthcare Reform Pharmaceuticals Regulatory/Compliance Wall Street Beat Mylan Source Type: news